BioCatalystWatch
ABUSWorkspace / ABUS / OverviewCompany library
Arbutus Biopharma Corp logo

Arbutus Biopharma Corp

Arbutus Biopharma Corp (ABUS)

Website

Featured programme · imdusiran (AB-729) — i-LIVER

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Other pipelines

PD-L1

PreINDP1P2P3FilingApproved

HBV transcripts × HBx transcript

PreINDP1P2P3FilingApproved

Partner / License out

HBV surface antigen (HBsAg) × HBV polymerase antigen × HBV core antigen

PreINDP1P2P3FilingApproved

History / paused

HBV transcripts × HBx transcript

PreINDP1P2P3FilingApproved

HBV transcripts × HBx transcript

PreINDP1P2P3FilingApproved

HBV transcripts × HBx transcript

PreINDP1P2P3FilingApproved

HBV transcripts × HBx transcript

HBV transcripts × HBx transcript

PreINDP1P2P3FilingApproved

HBV RNA transcripts

PreINDP1P2P3FilingApproved

HBV core protein/capsid × HBV core dimer interface

PreINDP1P2P3FilingApproved

HBV core protein/capsid × HBV core dimer interface

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ABUS PR & News

PR & News

ABUS SEC archive